BACKGROUND: Although tight blood pressure control is crucial in reducing vascular complications of diabetes, primary care providers often fail to appropriately intensify antihypertensive medications. OBJECTIVE: To identify novel visit-based factors associated with intensification of antihypertensive medications in adults with diabetes. DESIGN: Non-concurrent prospective cohort study. PATIENTS: A total of 254 patients with type 2 diabetes and hypertension enrolled in an academically affiliated managed care program. Over a 24-month interval (1999-2001), we identified 1,374 visits at which blood pressure was suboptimally controlled (systolic BP >/= 140 mmHg or diastolic BP >/= 90 mmHg). MEASUREMENTS AND MAIN RESULTS: Intensification of antihypertensive medications at each visit was the primary outcome. Primary care providers intensified antihypertensive treatment in only 176 (13%) of 1,374 visits at which blood pressure was elevated. As expected, higher mean systolic and mean diastolic blood pressures were important predictors of intensification. Treatment was also more likely to be intensified at visits that were "routine" odds ratio (OR) 2.08; 95% Confidence Interval [95% CI] 1.36-3.18), or that paired patients with their usual primary care provider (OR 1.84; 95% CI 1.11-3.06). In contrast, several factors were associated with failure to intensify treatment, including capillary glucose >150 mg/dL (OR 0.54; 95% CI 0.31-0.94) and the presence of coronary heart disease (OR 0.61; 95% CI 0.38-0.95). Co-management by a cardiologist accounted partly for this failure (OR 0.65; 95% CI 0.41-1.03). CONCLUSIONS: Failure to appropriately intensify antihypertensive treatment is common in diabetes care. Clinical distractions and shortcomings in continuity and coordination of care are possible targets for improvement.
BACKGROUND: Although tight blood pressure control is crucial in reducing vascular complications of diabetes, primary care providers often fail to appropriately intensify antihypertensive medications. OBJECTIVE: To identify novel visit-based factors associated with intensification of antihypertensive medications in adults with diabetes. DESIGN: Non-concurrent prospective cohort study. PATIENTS: A total of 254 patients with type 2 diabetes and hypertension enrolled in an academically affiliated managed care program. Over a 24-month interval (1999-2001), we identified 1,374 visits at which blood pressure was suboptimally controlled (systolic BP >/= 140 mmHg or diastolic BP >/= 90 mmHg). MEASUREMENTS AND MAIN RESULTS: Intensification of antihypertensive medications at each visit was the primary outcome. Primary care providers intensified antihypertensive treatment in only 176 (13%) of 1,374 visits at which blood pressure was elevated. As expected, higher mean systolic and mean diastolic blood pressures were important predictors of intensification. Treatment was also more likely to be intensified at visits that were "routine" odds ratio (OR) 2.08; 95% Confidence Interval [95% CI] 1.36-3.18), or that paired patients with their usual primary care provider (OR 1.84; 95% CI 1.11-3.06). In contrast, several factors were associated with failure to intensify treatment, including capillary glucose >150 mg/dL (OR 0.54; 95% CI 0.31-0.94) and the presence of coronary heart disease (OR 0.61; 95% CI 0.38-0.95). Co-management by a cardiologist accounted partly for this failure (OR 0.65; 95% CI 0.41-1.03). CONCLUSIONS: Failure to appropriately intensify antihypertensive treatment is common in diabetes care. Clinical distractions and shortcomings in continuity and coordination of care are possible targets for improvement.
Authors: D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz Journal: N Engl J Med Date: 1998-12-31 Impact factor: 91.245
Authors: Paul C Hicks; John M Westfall; Rebecca F Van Vorst; Caroline Bublitz Emsermann; L Miriam Dickinson; Wilson Pace; Bennett Parnes Journal: Diabetes Care Date: 2006-12 Impact factor: 19.112
Authors: Carel F Schaars; Petra Denig; Willeke N Kasje; Roy E Stewart; Bruce H R Wolffenbuttel; Flora M Haaijer-Ruskamp Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112
Authors: Lisa A Cooper; L Ebony Boulware; Edgar R Miller; Sherita Hill Golden; Kathryn A Carson; Gary Noronha; Mary Margaret Huizinga; Debra L Roter; Hsin-Chieh Yeh; Lee R Bone; David M Levine; Felicia Hill-Briggs; Jeanne Charleston; Miyong Kim; Nae-Yuh Wang; Hanan Aboumatar; Jennifer P Halbert; Patti L Ephraim; Frederick L Brancati Journal: Am J Public Health Date: 2013-09-12 Impact factor: 9.308
Authors: Lisa A Cooper; Debra L Roter; Kathryn A Carson; Lee R Bone; Susan M Larson; Edgar R Miller; Michael S Barr; David M Levine Journal: J Gen Intern Med Date: 2011-07-06 Impact factor: 5.128
Authors: Cynthia M Boyd; Bruce Leff; Jennifer L Wolff; Qilu Yu; Jing Zhou; Cynthia Rand; Carlos O Weiss Journal: J Am Geriatr Soc Date: 2011-05 Impact factor: 5.562
Authors: Stacie L Daugherty; J David Powers; David J Magid; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Julie A Schmittdiel; P Michael Ho Journal: Hypertension Date: 2012-06-25 Impact factor: 10.190
Authors: Magaly Ramirez; Richard Maranon; Jeffery Fu; Janet S Chon; Kimberly Chen; Carol M Mangione; Gerardo Moreno; Douglas S Bell Journal: J Am Med Inform Assoc Date: 2018-09-01 Impact factor: 4.497
Authors: Martin Thoenes; Ulrich Tebbe; Ludger Rosin; W Dieter Paar; Peter Bramlage; Wilhelm Kirch; Michael Böhm Journal: Clin Res Cardiol Date: 2011-01-05 Impact factor: 5.460
Authors: Brandon K Bellows; Natalia Ruiz-Negrón; Kirsten Bibbins-Domingo; Jordan B King; Mark J Pletcher; Andrew E Moran; Valy Fontil Journal: Circ Cardiovasc Qual Outcomes Date: 2019-06-05
Authors: Linda M Gerber; Samuel J Mann; Margaret V McDonald; Ya-Lin Chiu; Sridevi Sridharan; Penny H Feldman Journal: Am J Hypertens Date: 2012-12-28 Impact factor: 2.689
Authors: Ian M Kronish; Nathalie Moise; Thomas McGinn; Yan Quan; William Chaplin; Benjamin D Gallagher; Karina W Davidson Journal: J Gen Intern Med Date: 2016-06-02 Impact factor: 5.128
Authors: Ana H Traylor; Usha Subramanian; Connie S Uratsu; Carol M Mangione; Joe V Selby; Julie A Schmittdiel Journal: Diabetes Care Date: 2009-12-15 Impact factor: 17.152